~~<i id='6E051C2DE4'><strike id='6E051C2DE4'><tt id='6E051C2DE4'><pre id='6E051C2DE4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：comprehensive 2025-10-01 20:12:17 - browse：5217

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Biden's 'march

entertainment

leisure time

entertainment

focus

explore

hotspot

AlexHogan/STATGenerativeAIishavingamoment.PeterLee,whooverseesMicrosoft’sapproachtohealthcareandco-a

WSS

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Fetal cell organoids grown from amniotic fluid, study finds

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Why you shouldn’t ask, “What country has the best health care?”

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

State of the Union pitch: Bigger Medicare drug price negotiations

leisure time

entertainment

entertainment

How one medical school became remarkably diverse

Philips to halt sales of sleep apnea machines in U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Medicare drug price negotiation hearing pits pharma v Biden admin

DIEP, the 'gold standard' of breast reconstruction, is under threat

FTC sues over Novant Health acquisition of two N.C. hospitals

Virginia high school admissions case could be legal follow

The public health thinking behind the CDC’s new Covid guidance

Medicare details structure of new drug price negotiation program

Biogen walks away from Aduhelm, years after polarizing approval

leisure time

Pregnant women don't need prenatal multivitamins, study concludes

Longer MASH drug regimen improved liver, Akero study finds

Boston competes with Raleigh

Ozempic has benefits for kidney disease as well as diabetes

Longer MASH drug regimen improved liver, Akero study finds

Vertex non

entertainment

focus

explore

hotspot